ECLIPSE BIOINNOVATIONS
Eclipse Bioinnovations is a leading RNA genomics company founded in 2017 based on technology developed at the University of California, San Diego. Eclipse's mission is to use their pioneering RNA genomics platform technologies to advance RNA medicines and scientific discovery. Eclipse’s founders developed eCLIP, the world’s most efficient and unique CLIP-seq technology for identifying RNA binding protein gene partners and gene maps. Eclipse’s suite of RNA genomics technologies now cover e... CLIP-RBP for mapping the RNA binding proteins, miR-eCLIP for the miR-interactome, m6A-eCLIP for RNA modifications, End-Seq for 5' and 3' mapping, and FLI-Seq for simplifying Crispr library prep. Products are offered as services and kit for biopharma companies and academic researchers, and can be customized for clients.
ECLIPSE BIOINNOVATIONS
Industry:
Biotechnology Life Science
Founded:
2017-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.eclipsebio.com
Total Employee:
11+
Status:
Active
Contact:
(855) 727-2547
Email Addresses:
[email protected]
Total Funding:
25.95 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Alloy Therapeutics
Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Creyon Bio
Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Lycia Therapeutics
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Advisors List
Current Employees Featured
Founder
Investors List
Photon Venture Alpha
Photon Venture Alpha investment in Series A - Eclipse Bioinnovations
iGlobe
iGlobe investment in Series A - Eclipse Bioinnovations
Phoenix Venture Partners
Phoenix Venture Partners investment in Series A - Eclipse Bioinnovations
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Eclipse Bioinnovations
Official Site Inspections
http://www.eclipsebio.com Semrush global rank: 2.75 M Semrush visits lastest month: 5.9 K
- Host name: 23.185.0.3
- IP address: 23.185.0.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Eclipse Bioinnovations"
About us - Eclipsebio
Eclipsebio's foundation is our portfolio of next-generation assays and analyses, tailored for the development of RNA-based and RNA-targeting medicines. From revealing how LNP formulations affect structure and the shelf life of RNA …See details»
Leadership | Eclipsebio
The talented team at Eclipsebio represents a wide spectrum of science and computational disciplines, giving us a unique and integrated perspective on RNA genomics. ... Prior to …See details»
Eclipse Bioinnovations - Crunchbase Company Profile …
Contact Email [email protected] Phone Number (855) 727-2547 Eclipse Bioinnovations is a leading RNA genomics company founded in 2017 based on technology developed at the University of California, San Diego.See details»
Eclipsebio CEO and Key Executive Team | Craft.co
Eclipsebio's Co-Founder, CEO, Board Member is Peter Chu. Other executives include Karen Chapman, Chief Scientific Officer; Alexander Shishkin, Co-Founder, Director of Research and …See details»
Eclipsebio - LinkedIn
Eclipsebio develops first-in-class technologies, analyses, and platforms for the development of tomorrow’s RNA-based and RNA-targeting therapies.See details»
Eclipsebio Company Profile - Craft
Eclipsebio (also known as Eclipse Bioinnovations) is a biotechnology company that provides ribonucleic acid (RNA) genomics products and services. It specializes in oligonucleotide …See details»
Eclipse BioInnovations Inc - VentureRadar
Eclipsebio's eMERGE partnership platform offers comprehensive characterization and precision optimization of RNA-based therapeutics. They also perform multiomic profiling to reveal …See details»
Eclipsebio Launches eMERGE™ Platform, a Cutting-Edge End-to …
SAN DIEGO, July 24, 2024--Eclipsebio Launches eMERGEâ„¢ Platform, a Cutting-Edge End-to-End Solution for the Characterization and Optimization of RNA-Based Therapeutic ProductsSee details»
Eclipsebio | RNA Leaders USA - Informa Connect
Eclipsebio is a private biotechnology company headquartered in San Diego, developing first-in-class technologies to accelerate the development of tomorrow’s key RNA genomics …See details»
Contact us - Eclipsebio
Organization* * Phone number. Technology name(s) End-Seq. eRibo. eSENSE dsRNA. eSENSE m6A. eSHAPE. m6A-eCLIP ... Submit. Discover the latest in RNA. Subscribe to stay up-to …See details»
Biotech startup Eclipsebio emerges to shed light on RNA drug …
Mar 15, 2022 Eclipsebio’s initial research was supported by $4.5 million from multiple grants. The company also closed two prior seed rounds whose total dollar value remains undisclosed.See details»
Eclipse-bio - Crunchbase Company Profile & Funding
Sep 6, 2024 Organization. Eclipse-bio . Connect to CRM . Save . Summary. People. Technology. Signals & News. About. Eclipse-bio is committed to bringing affordable best in …See details»
Eclipsebio Announces a $14 Million Series A Financing to Advance …
Mar 15, 2022 Eclipsebio is a private biotechnology company building the leading RNA genomics team to develop first-in-class technologies to enable faster and more effective development …See details»
Eclipsebio Expands Intellectual Property Portfolio to Support New ...
Sep 27, 2022 Eclipsebio has executed three separate license agreements. The first is a co-exclusive license from Stanford University for IP related to probes of RNA structure and …See details»
Eclipsebio launches eMERGEâ„¢ platform
Jul 24, 2024 Eclipsebio will unveil eMERGE at Hanson Wade’s 4 th Annual mRNA-Based Therapeutics Summit on July 30, 2024. About Eclipsebio Eclipsebio is a private biotechnology …See details»
Eclipsebio Launches eSHAPEâ„¢ Product Family to Provide RNA
Feb 7, 2023 SAN DIEGO--(BUSINESS WIRE)-- Eclipse Bioinnovations (Eclipsebio), a leading RNA genomics company developing and commercializing novel, data-driven technologies that …See details»
Eclipse Bioinnovations Closes $14M Series A Financing Round
Mar 15, 2022 A University of California, San Diego spinout, Eclipsebio offers technologies revealing RNA interactions with RNA binding proteins, RNA modifications such as m6A, …See details»
Bioinformatics | Eclipsebio
At Eclipsebio we know that data interpretation is just as important as data generation, which is why we also include comprehensive analytical support from our team of bioinformatics …See details»
Capabilities | Eclipsebio
At Eclipsebio we value innovation and are continually developing new assays and workflows to improve therapeutic development. If you would like to obtain early access to our newest …See details»